Herceptin and the heart--a molecular modifier of cardiac failure

N Engl J Med. 2006 Feb 23;354(8):789-90. doi: 10.1056/NEJMp058315.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adaptor Proteins, Signal Transducing
  • Animals
  • Anthracyclines / adverse effects
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Breast Neoplasms / drug therapy*
  • Carrier Proteins / metabolism
  • Genes, erbB-2
  • Heart / drug effects
  • Heart Diseases / chemically induced
  • Heart Failure / chemically induced*
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Mice
  • Receptor, ErbB-2 / immunology*
  • Signal Transduction
  • Trastuzumab

Substances

  • Adaptor Proteins, Signal Transducing
  • Anthracyclines
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Carrier Proteins
  • ERBIN protein, human
  • Erbb2ip protein, mouse
  • Intracellular Signaling Peptides and Proteins
  • Receptor, ErbB-2
  • Trastuzumab